SLSN — Solesence, Inc. Common Stock

Summary of SLSN Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Revenue: $14.5 million, down 14% year-over-year, attributed to a challenging comparison with a record Q3 2024.
• Gross Profit: $3.4 million, compared to $6.1 million in Q3 2024; gross margin decreased to 23% from 36%.
• Operating Expenses: Increased to $4.2 million from $2.9 million in the prior year, driven by higher employee costs, legal fees, and expenses related to Nasdaq uplisting.
• Net Loss: $1.1 million, a decline from net income of $3 million in Q3 2024.
• Adjusted EBITDA: Loss of $435,000 compared to a profit of $3.6 million in the same quarter last year.
• Open Orders: Increased to $64 million from $34 million year-over-year, indicating potential future revenue.

2. Strategic Updates and Business Highlights

• Leadership Transition: Kevin Carrington has taken over as CEO from Jess Jankowski, who emphasized the company's innovation and patent portfolio.
• Product Development: A new unified group for product design and integrity has been established to enhance product quality and efficiency.
• Labor Efficiency Improvements: Significant reductions in labor costs (down 25% per unit) and improved operational capacity were noted due to automation and restructuring.
• Inventory Management: Enhanced controls are being implemented to manage the complexity of a broader product range, which has increased significantly over the past six years.

3. Forward Guidance and Outlook

• Revenue Growth: The company expects to see an overall revenue increase for the full year, projecting a $10 million increase over the previous year.
• Margin Recovery: Management aims to restore gross margins to around 30% and eventually target margins above 40% in the future.
• 2026 Outlook: While refraining from specific guidance due to market uncertainties, the company anticipates growth at a rate exceeding the industry average.

4. Bad News, Challenges, or Points of Concern

• Declining Revenue: Q3 2025 marked the first year-over-year revenue decline in nearly two years, raising concerns about sales performance.
• Operational Inefficiencies: Ongoing challenges in product design, labor efficiency, and inventory control have hindered growth and profitability.
• Increased Operating Costs: Rising SG&A expenses and legal costs have impacted profitability, with some costs expected to persist in the near term.
• Market Conditions: The beauty industry is experiencing a slowdown, which could affect future growth despite the company's strong positioning in mineral-based SPF products.

5. Notable Q&A Insights

• Concerns on Mistakes: Questions arose regarding repeated operational mistakes and their impact on financial performance, with management acknowledging the need for improvement.
• ERC Payment Impact: Clarification was provided that a $1.2 million ERC payment positively impacted Q3 results, raising concerns about underlying financial health without such one-time benefits.
• Sales Forecasting: Management expressed confidence in achieving revenue growth in Q4 2025, despite current challenges, and emphasized the importance of brand partners' inventory strategies.
• Investor Communication: Plans for an investor presentation were announced to provide further clarity on the company's strategy and outlook, especially in light of recent stock performance declines.

This summary encapsulates the critical aspects of the earnings call, highlighting both the challenges faced by Solesence, Inc. and the strategic initiatives being implemented to drive future growth.